应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VNDA 万达生物制药
未开盘 07-18 16:00:00 EDT
6.07
-0.15
-2.41%
盘后
6.20
+0.13
+2.14%
19:10 EDT
最高
6.33
最低
5.89
成交量
89.02万
今开
6.15
昨收
6.22
日振幅
7.07%
总市值
3.53亿
流通市值
3.17亿
总股本
5,820万
成交额
540.15万
换手率
1.70%
流通股本
5,226万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.14%
自选股智能写手 · 02:53
Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.14%
Vanda Pharmaceuticals Inc.盘中异动 早盘急速拉升5.37%报5.49美元
自选股智能写手 · 07-11
Vanda Pharmaceuticals Inc.盘中异动 早盘急速拉升5.37%报5.49美元
未来制药撤回收购万达制药的要约
Reuters · 06-27
未来制药撤回收购万达制药的要约
Vanda Pharmaceuticals Inc.盘中异动 早盘快速下挫6.57%报5.92美元
自选股智能写手 · 06-20
Vanda Pharmaceuticals Inc.盘中异动 早盘快速下挫6.57%报5.92美元
BUZZ-万达医药拒绝收购要约,股价下跌
Reuters · 06-20
BUZZ-万达医药拒绝收购要约,股价下跌
万达拒绝 Future Pak 和 Cycle Pharma 的收购要约
Reuters · 06-20
万达拒绝 Future Pak 和 Cycle Pharma 的收购要约
Vanda Pharmaceuticals Inc.盘中异动 急速拉升5.45%
自选股智能写手 · 06-18
Vanda Pharmaceuticals Inc.盘中异动 急速拉升5.45%
今日优惠-兼并与收购
Reuters · 06-13
今日优惠-兼并与收购
今日优惠-兼并与收购
Reuters · 06-13
今日优惠-兼并与收购
BUZZ-未来包装提高收购要约的现金部分,万达跳涨
Reuters · 06-13
BUZZ-未来包装提高收购要约的现金部分,万达跳涨
未来包装提高对旺达收购要约的现金部分比例
Reuters · 06-13
未来包装提高对旺达收购要约的现金部分比例
BUZZ--美国股票走势-罗宾hood、JM Smucker、Novavax
Reuters · 06-06
BUZZ--美国股票走势-罗宾hood、JM Smucker、Novavax
BUZZ-循环制药公司提出收购要约后,万达公司股价上涨
Reuters · 06-06
BUZZ-循环制药公司提出收购要约后,万达公司股价上涨
万达生物制药(VNDA.US)盘前涨近25% 传Cycle Pharmacecals提出每股8美元收购要约
智通财经网 · 06-06
万达生物制药(VNDA.US)盘前涨近25% 传Cycle Pharmacecals提出每股8美元收购要约
BUZZ--美国股票走势-Nvidia、Vista Outdoor、Robinhood
Reuters · 06-06
BUZZ--美国股票走势-Nvidia、Vista Outdoor、Robinhood
BUZZ-万达因报导 Cycle Pharma 的收购要约而上涨
Reuters · 06-06
BUZZ-万达因报导 Cycle Pharma 的收购要约而上涨
BUZZ-万达因报道 Cycle Pharma 的收购要约而上涨
Reuters · 06-06
BUZZ-万达因报道 Cycle Pharma 的收购要约而上涨
媒体-Cycle Pharma 向 Vanda Pharmaceuticals 发起收购要约 - 彭博新闻社
Reuters · 06-06
媒体-Cycle Pharma 向 Vanda Pharmaceuticals 发起收购要约 - 彭博新闻社
Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.35%
自选股智能写手 · 05-28
Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.35%
BUZZ-万达医药拒绝 Future Pak 修改后的收购要约后下跌
Reuters · 05-25
BUZZ-万达医药拒绝 Future Pak 修改后的收购要约后下跌
公司概况
公司名称:
万达生物制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vanda Pharmaceuticals Inc.于2002年在特拉华州注册成立。该公司是一家全球领先的生物制药公司,专注于创新疗法的开发和商业化,以解决高度未满足的医疗需求并改善患者的生活。该公司努力推进新的方法,通过负责任的创新将重要的新药推向市场。该公司致力于在药物发现、临床试验和产品的商业定位中使用支持健全科学的技术,包括遗传学和基因组学。
发行价格:
--
{"stockData":{"symbol":"VNDA","market":"US","secType":"STK","nameCN":"万达生物制药","latestPrice":6.07,"timestamp":1721332800000,"preClose":6.22,"halted":0,"volume":890244,"hourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.07,"latestTime":"19:10 EDT","volume":15176,"amount":92136.5,"timestamp":1721344210326},"delay":0,"floatShares":52262142,"shares":58198273,"eps":-0.090066,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.15,"latestTime":"07-18 16:00:00 EDT","open":6.15,"high":6.33,"low":5.89,"amount":5401512.738288,"amplitude":0.07074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.090066,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1721376000000},"adr":0,"listingDate":1144814400000,"adjPreClose":6.22,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.15,"preClose":6.22,"latestTime":"09:29 EDT","volume":1471,"amount":9153.6303873,"timestamp":1721309399999},"postHourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.07,"latestTime":"19:10 EDT","volume":15176,"amount":92136.5,"timestamp":1721344210326},"volumeRatio":0.902517,"impliedVol":0.1578,"impliedVolPercentile":0.0079},"requestUrl":"/m/hq/s/VNDA/wiki","defaultTab":"wiki","newsList":[{"id":"2452941455","title":"Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452941455","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452941455?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:53","pubTimestamp":1721328793,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时53分,Vanda Pharmaceuticals Inc.股票出现波动,股价急速跳水5.14%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.94%。其相关个股中,Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大,Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃,换手率分别为3281.44%、2682.13%、1309.10%,振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.,振幅分别为93.33%、91.50%、86.24%。大部分收入来自 HETLIOZ 产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719025314aefa5baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719025314aefa5baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2450822363","title":"Vanda Pharmaceuticals Inc.盘中异动 早盘急速拉升5.37%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450822363","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450822363?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:30","pubTimestamp":1720704649,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时30分,Vanda Pharmaceuticals Inc.股票出现波动,股价急速拉升5.37%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为1.43%。Vanda Pharmaceuticals Inc.公司简介:万达生物制药公司是一家生物制药公司,从事疗法的开发和商业化,以满足高度未满足的医疗需求并改善患者的生活。消息层面,截至21时30分,《坎托·菲茨杰拉德首予万达生物制药买入评级,目标价11美元》资讯为影响Vanda Pharmaceuticals Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213050941f6410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711213050941f6410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2446341923","title":"未来制药撤回收购万达制药的要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2446341923","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446341923?lang=zh_cn&edition=full","pubTime":"2024-06-27 05:51","pubTimestamp":1719438688,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月26日 - 合同生产商Future Pak周三表示,它将撤回收购万达制药 的要约,立即生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2444212106","title":"Vanda Pharmaceuticals Inc.盘中异动 早盘快速下挫6.57%报5.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444212106","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444212106?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:31","pubTimestamp":1718890309,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时31分,Vanda Pharmaceuticals Inc.股票出现波动,股价大幅下挫6.57%。截至发稿,该股报5.92美元/股,成交量25.0322万股,换手率0.43%,振幅1.63%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Vanda Pharmaceuticals Inc.公司简介:万达生物制药公司是一家生物制药公司,从事疗法的开发和商业化,以满足高度未满足的医疗需求并改善患者的生活。大部分收入来自 HETLIOZ 产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131499f52d647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406202131499f52d647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2444298630","title":"BUZZ-万达医药拒绝收购要约,股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2444298630","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444298630?lang=zh_cn&edition=full","pubTime":"2024-06-20 17:17","pubTimestamp":1718875079,"startTime":"0","endTime":"0","summary":" 6月20日 - ** 制药商旺达制药 股价盘前下跌6%至约6美元** 周三晚些时候,VNDA拒绝了Cycle Pharmaceutical提出的 收购要约和Future Pak提出的修订收购要约,并表示这两个收购要约都大大低估了公司的价值。** 英国 Cycle Pharma 公司本月早些时候提出的每股 8 美元的现金收购要约将使 Vanda 的价值达到 4.66 亿美元。** 截至上次收盘,旺达股价年累计上涨 50.24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA","BUZZ"],"gpt_icon":0},{"id":"2444238193","title":"万达拒绝 Future Pak 和 Cycle Pharma 的收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2444238193","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444238193?lang=zh_cn&edition=full","pubTime":"2024-06-20 08:59","pubTimestamp":1718845145,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月20日 - 旺达制药 周三表示,该公司拒绝了英国Cycle Pharmaceutical公司的收购要约和合同制造商Future Pak公司的修订要约,并称这两份要约都低估了这家美国制药商的价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2444819429","title":"Vanda Pharmaceuticals Inc.盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444819429","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444819429?lang=zh_cn&edition=full","pubTime":"2024-06-18 00:26","pubTimestamp":1718641616,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日00时26分,Vanda Pharmaceuticals Inc.股票出现波动,股价急速拉升5.45%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.55%。Vanda Pharmaceuticals Inc.公司简介:万达生物制药公司是一家生物制药公司,从事疗法的开发和商业化,以满足高度未满足的医疗需求并改善患者的生活。大部分收入来自 HETLIOZ 产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618002656aef54c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618002656aef54c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2443689852","title":"今日优惠-兼并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2443689852","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443689852?lang=zh_cn&edition=full","pubTime":"2024-06-13 21:43","pubTimestamp":1718286217,"startTime":"0","endTime":"0","summary":" 路透6月13日 - 截至格林尼治标准时间周四13时30分,有以下竞标、兼并、收购和处置的报道: ** 印度 Ambuja 水泥公司 称已收购 Penna 水泥工业公司 ,企业价值为 1042.2 亿卢比(12.5 亿美元。** 澳大利亚竞争监管机构对 Sigma Healthcare 公司 与零售商 Chemist Warehouse Group 合并组建一家价值 88 亿澳元 公司的提议表示严重关切。** 澳大利亚澳航 表示,将以2.11亿澳元收购在线旅游企业TripADeal剩余的49%股份,因为该航空公司寻求利用假日预订的强劲需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7103","QAN.AU","SIG.AU","VNDA","BK7030","BK4139","SPE"],"gpt_icon":0},{"id":"2443689850","title":"今日优惠-兼并与收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2443689850","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443689850?lang=zh_cn&edition=full","pubTime":"2024-06-13 21:43","pubTimestamp":1718286217,"startTime":"0","endTime":"0","summary":" 路透6月13日 - 截至格林尼治标准时间周四13时30分,有以下竞标、兼并、收购和处置的报导: ** 印度 Ambuja 水泥公司 称已收购 Penna 水泥工业公司 ,企业价值为 1042.2 亿卢比(12.5 亿美元。** 澳大利亚竞争监管机构对 Sigma Healthcare 公司 与零售商 Chemist Warehouse Group 合并组建一家价值 88 亿澳元 公司的提议表示严重关切。** 澳大利亚澳航 表示,将以2.11亿澳元收购在线旅游企业TripADeal剩余的49%股份,因为该航空公司寻求利用假日预订的强劲需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QAN.AU","SIG.AU","SPE","BK4139","BK7103","BK7030","VNDA"],"gpt_icon":0},{"id":"2443688142","title":"BUZZ-未来包装提高收购要约的现金部分,万达跳涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2443688142","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443688142?lang=zh_cn&edition=full","pubTime":"2024-06-13 20:47","pubTimestamp":1718282867,"startTime":"0","endTime":"0","summary":" 6月13日 - ** 万达制药 股价盘前上涨5.2%至6.23美元 ** 私营合同制造商Future Pak提交了收购co的最后申请,并提高了现金部分的报价 ** Future Pak 将现金部分的收购报价提高到每股 8.50 美元至 9.00 美元,加上之前提出的或有价值权,总对价为每股 12.77 美元至 13.27 美元。** Future Pak 将万达参与讨论的最后期限定为 6 月 26 日,否则将撤回收购要约。** 截至最后收盘,股价年累计上涨 40.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139","BUZZ"],"gpt_icon":0},{"id":"2443500506","title":"未来包装提高对旺达收购要约的现金部分比例","url":"https://stock-news.laohu8.com/highlight/detail?id=2443500506","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443500506?lang=zh_cn&edition=full","pubTime":"2024-06-13 20:27","pubTimestamp":1718281627,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透6月13日 - Future Pak公司周四表示,它已提交了收购万达制药公司 的最终方案,并提高了现金部分的报价。 万达此前拒绝了Future Pak的提议,称其报价严重低估了公司价值,不符合公司及其股东的最佳利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2441712514","title":"BUZZ--美国股票走势-罗宾hood、JM Smucker、Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2441712514","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441712514?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:18","pubTimestamp":1717679913,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月6日 - 标普500指数和道指期货周四在震荡交投中走低,此前失业救济金申请数据显示美国劳动力市场日益疲软,而纳斯达克指数期货表现出色,原因是人工智能热门股Nvidia的上涨提振了科技板块的乐观情绪。美东时间9:01,道指电子盘 下跌0.01%,报38881点。标普500指数小型股 上涨0.01%,报5366.5点;纳斯达克100指数小型股 上涨0.11%,报19095点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4220","SMAR","BIG","BK4548","BK4543","BK4155","BK4587","MPC","NVDA","BK4547","BK4166","BK4200","LU0276348264.USD","LULU","BK4549","DLTR","BK4212","GPCR","IE0009356076.USD","NVAX","SJM","VSCO","ACHR","DINO","LU0320765059.SGD","BK4588","LU1861217088.USD","ABM","VSTO","LU0456854461.SGD","LPG","FIVE","BK4023","IE00BFSS7M15.SGD","IE00BMPRXR70.SGD","LU0348723411.USD","ANNX","LU0061475181.USD","LU0823411888.USD","LU0266512127.USD","COF","HOOD","LU1861220207.SGD","BK4144","BK4127","DK","VNDA","PBF","BUZZ","CXM"],"gpt_icon":0},{"id":"2441711358","title":"BUZZ-循环制药公司提出收购要约后,万达公司股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441711358","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441711358?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:49","pubTimestamp":1717678192,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) (更新信息) 6月6日 - ** Vanda Pharmaceuticals 股价盘前大涨25.5%至6.34美元** 总部位于英国的Cycle Pharmaceuticals公司建议 (link),以每股8美元的价格收购该公司,现金总价为4.66亿美元。** 收购价比 Vanda 上次收盘价 5.05 美元溢价 58.4** VNDA 没有立即回应路透的置评请求** 公司此前拒绝了 (link) Future Pak的收购建议,称该建议低估了VNDA的价值,不符合公司及其股东的最佳利益。** 截至上一交易日收盘,股价累计上涨约 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","VNDA"],"gpt_icon":0},{"id":"2441151867","title":"万达生物制药(VNDA.US)盘前涨近25% 传Cycle Pharmacecals提出每股8美元收购要约","url":"https://stock-news.laohu8.com/highlight/detail?id=2441151867","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441151867?lang=zh_cn&edition=full","pubTime":"2024-06-06 20:08","pubTimestamp":1717675683,"startTime":"0","endTime":"0","summary":"周四美股盘前,万达生物制药上涨近25%,此前有报道称,Cycle Pharmacecals主动提出收购要约。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240606/20240606194759_10615.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240606/20240606194759_10615.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1132325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2441106713","title":"BUZZ--美国股票走势-Nvidia、Vista Outdoor、Robinhood","url":"https://stock-news.laohu8.com/highlight/detail?id=2441106713","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441106713?lang=zh_cn&edition=full","pubTime":"2024-06-06 19:58","pubTimestamp":1717675116,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 6月6日 - 标普500指数和道指期货周四变动不大,投资者在等待衡量美国劳动力市场强劲程度的新数据;纳斯达克指数期货走高,原因是人工智能热门股Nvidia的上涨提振了科技板块的乐观情绪。美东时间7:33,道指电子盘 下跌0.07%,报38858点。标普500指数小型股 上涨0.01%,报5366.75点;纳斯达克100指数小型股 上涨0.12%,报19097.5点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1XK9C88.USD","BK4549","LU0082616367.USD","BK4548","BUZZ","FIVE","LU0648000940.SGD","IE00B1BXHZ80.USD","LU0061475181.USD","LU0353189680.USD","LU0300736062.USD","DINO","COF","NVDA","BK4534","CXM","IE00BKDWB100.SGD","LU0053666078.USD","LU0122376428.USD","MPC","LU0823411888.USD","ANNX","BK4532","IE00BFSS8Q28.SGD","LU0289960550.SGD","BK4547","IE0009356076.USD","BK4127","BK4166","LU0061474960.USD","VSTO","IE00B19Z9505.USD","LU0266512127.USD","BK4554","HOOD","LU0109391861.USD","VSCO","BK4533","VNDA","DK","PBF","IE0004445239.USD","LU0348723411.USD","IE00B7KXQ091.USD","LU0130102774.USD","LU0648001328.SGD","BK4539","LU0316494557.USD","LULU","LU0353189763.USD"],"gpt_icon":1},{"id":"2441903717","title":"BUZZ-万达因报导 Cycle Pharma 的收购要约而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441903717","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441903717?lang=zh_cn&edition=full","pubTime":"2024-06-06 19:14","pubTimestamp":1717672471,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月6日 - ** 旺达制药公司 股价盘前上涨17.8%至5.95美元** 据彭博新闻社援引知情人士的话报导,英国Cycle Pharmaceuticals公司主动提出收购万达公司。** 报导称,Cycle提出以每小时8美元的现金收购万达,这将使这家制药商的估值达到约4.6亿美元。** Cycle和万达没有立即回应路透的置评请求** 此前,万达拒绝了 (link),称Future Pak的收购提议低估了公司价值,不符合公司及其股东的最佳利益。** 截至上次收盘,万达股价年累计上涨约 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","VNDA","BK4139"],"gpt_icon":0},{"id":"2441790379","title":"BUZZ-万达因报道 Cycle Pharma 的收购要约而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441790379","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441790379?lang=zh_cn&edition=full","pubTime":"2024-06-06 19:14","pubTimestamp":1717672471,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月6日 - ** 旺达制药公司 股价盘前上涨17.8%至5.95美元** 据彭博新闻社援引知情人士的话报道,英国Cycle Pharmaceuticals公司主动提出收购万达公司。** 报道称,Cycle提出以每小时8美元的现金收购万达,这将使这家制药商的估值达到约4.6亿美元。** Cycle和万达没有立即回应路透的置评请求** 此前,万达拒绝了 (link),称Future Pak的收购提议低估了公司价值,不符合公司及其股东的最佳利益。** 截至上次收盘,万达股价年累计上涨约 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139","BUZZ"],"gpt_icon":0},{"id":"2441794749","title":"媒体-Cycle Pharma 向 Vanda Pharmaceuticals 发起收购要约 - 彭博新闻社","url":"https://stock-news.laohu8.com/highlight/detail?id=2441794749","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441794749?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:33","pubTimestamp":1717670020,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月6日 - -- 来源链接: -- 注:路透未核实此报道,不保证其准确性","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2438595377","title":"Vanda Pharmaceuticals Inc.盘中异动 快速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438595377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438595377?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:34","pubTimestamp":1716903293,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时34分,Vanda Pharmaceuticals Inc.股票出现波动,股价急速下跌5.35%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.06%。Vanda Pharmaceuticals Inc.公司简介:万达生物制药公司是一家生物制药公司,从事疗法的开发和商业化,以满足高度未满足的医疗需求并改善患者的生活。大部分收入来自 HETLIOZ 产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213453af8ab318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528213453af8ab318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2438809451","title":"BUZZ-万达医药拒绝 Future Pak 修改后的收购要约后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2438809451","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438809451?lang=zh_cn&edition=full","pubTime":"2024-05-25 06:11","pubTimestamp":1716588681,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 5月24日 - ** 旺达制药 股价在盘后交易中下跌1.2%,报5.17美元** 公司称 (link) 董事会拒绝了 (link) Future Pak 的 \"主动 \"收购提议** VNDA 称,私营合同制造商修改后的报价 (link) 为每股 7.25 美元至 7.75 美元,\"大大低估了 \"公司的价值。** Future Pak 没有立即回应路透的置评请求** 截至上一交易日收盘,股价年累计上涨约 24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vandapharma.com","stockEarnings":[{"period":"1week","weight":0.0466},{"period":"1month","weight":-0.0426},{"period":"3month","weight":0.1879},{"period":"6month","weight":0.6585},{"period":"1year","weight":-0.0441},{"period":"ytd","weight":0.4384}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.1161},{"period":"6month","weight":0.1456},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vanda Pharmaceuticals Inc.于2002年在特拉华州注册成立。该公司是一家全球领先的生物制药公司,专注于创新疗法的开发和商业化,以解决高度未满足的医疗需求并改善患者的生活。该公司努力推进新的方法,通过负责任的创新将重要的新药推向市场。该公司致力于在药物发现、临床试验和产品的商业定位中使用支持健全科学的技术,包括遗传学和基因组学。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.022786},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.012763},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.017891},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.012406},{"month":5,"riseRate":0.5,"avgChangeRate":0.809984},{"month":6,"riseRate":0.578947,"avgChangeRate":0.046161},{"month":7,"riseRate":0.421053,"avgChangeRate":-0.027825},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.003709},{"month":9,"riseRate":0.277778,"avgChangeRate":-0.049836},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005894},{"month":11,"riseRate":0.611111,"avgChangeRate":0.041358},{"month":12,"riseRate":0.555556,"avgChangeRate":0.02629}],"exchange":"NASDAQ","name":"万达生物制药","nameEN":"Vanda Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万达生物制药(VNDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万达生物制药(VNDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万达生物制药,VNDA,万达生物制药股票,万达生物制药股票老虎,万达生物制药股票老虎国际,万达生物制药行情,万达生物制药股票行情,万达生物制药股价,万达生物制药股市,万达生物制药股票价格,万达生物制药股票交易,万达生物制药股票购买,万达生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万达生物制药(VNDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万达生物制药(VNDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}